Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

CDRH Dispute Resolution Guidance Spells Out Panel Membership, Timeframes

This article was originally published in The Gray Sheet

Executive Summary

The dispute resolution panel proposed by FDA's Center for Devices and Radiological Health will consist of eight members, one of whom will be a non-voting industry representative, the agency says in a draft guidance document released April 27.

You may also be interested in...



ODE Adding Third Deputy Director; Feigal Outlines CDRH Ombudsman Role

The Center for Devices and Radiological Health's next Office of Device Evaluation Director will possess a medical degree, CDRH Director David Feigal said in a Nov. 9 interview with "The Gray Sheet."

ODE Adding Third Deputy Director; Feigal Outlines CDRH Ombudsman Role

The Center for Devices and Radiological Health's next Office of Device Evaluation Director will possess a medical degree, CDRH Director David Feigal said in a Nov. 9 interview with "The Gray Sheet."

Dispute Resolution Panel Plans Solidify As CDRH Weighs Industry Comments

FDA intends to publish a Federal Register notice within the next three weeks seeking applicants to fill three standing voting positions on its Medical Devices Dispute Resolution Panel, as well as one industry and one consumer representative, according to FDA staffers.

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

MT011691

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel